Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. 

Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. 

In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers’ needs, based on profound experience with EU and FDA regulations. 

Cellex also stands for a successful tech transfer of processes from US to Europe. 

Our apheresis center is specialized in collections of different starting materials from healthy and diseased donors. Cellex runs its own highly diverse donor pool and offers fresh leukopaks, mobilized cells, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. 

IT and transport solutions complete the Cellex portfolio. 

WhiteLab Genomics is a fast-growing in-silico deeptech start-up that is reinventing the research and early development of new genomic medicines. We are developing and using Artificial Intelligence to accelerate the discovery, design and bioproduction of these innovative biotherapies. We are collaborating with top notch academics, biotech companies, and pharmaceutical firms in Europe and North America, to tackle significant challenges in developing innovative genomic medicines notably for rare diseases, neurodegenerative diseases, oncology, ophthalmology. 

Scinus Cell Expansion provides technologies and process development to enable and improve cell therapy and regenerative medicine. Our main product is the SCINUS bioreactor NG, which is a closed bioreactor system for the controlled cultivation of cells, supporting R&D as well as GMP processes. Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique, volume-expandable, rocking platform that provides an optimally homogenized culture environment with minimal shear stresses. Two different single use bioreactor bag can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells), as well as suspension cells (e.g. T-cells, NK cells) to clinically relevant numbers. Both bags can be used with the same Scinus Cell Expansion system configuration. For an illustrative animation, please check our website (www.scinus.com).